Pharma & Biotech
-
Boathouse Row to Light Up for Rare Disease Day, Says King of Prussia’s CSL Behring CEO
“Our collective hope shines a light on the progress made and challenges ahead,” CSL Behring Limited CEO and Managing Director Paul Perreault said in a video message to 25,000 employees. “Today, the rare disease community joins together to recognize Rare Disease Day. It’s a day, above all, that represents connection and hope. On February 28th, as…
-
Analytical Testing Services Laboratory in King of Prussia Aims to Add Jobs, Address Needs for Cell, Gene Therapy
The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address growing capacity needs for the cell and gene therapy sector of life sciences companies, writes John George for the Philadelphia Business Journal. The lab testing and analytical services business will…
-
Main Line CEO Scott Braunstein Makes Top 25 Biotech CEO List
The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled by The Healthcare Technology Report. Dr. Braunstein, of Marinus Pharmaceuticals, came in at No. 11. Marinus focuses on improving the lives of patients with seizure disorders. Dr. Braunstein was named CEO in…
-
CSL Behring Partners with Uplifting Athletes for Rare Disease Research and Honors Those Making an Impact
At the celebratory event, presented by global biotherapies leader CSL Behring, Uplifting Athletes awarded $180,000 in research grants to nine promising young investigative rare disease researchers and honored the six newest members of the organization’s Rare Disease Championship Team―an exemplary group of college football players who support Uplifting Athletes’ mission to inspire the Rare Disease Community…
-
Abington Scientist Katalin Kariko One of Time Magazine’s 2021 Heroes of the Year
Abington’s Katalin Kariko is one of the Heroes of the Year, a group of scientists who introduced an innovative and highly effective mRNA-based vaccine platform to the world that will have a huge impact on our health and well-being far beyond COVID-19, write Alice Park and Jamie Ducharme for Time. Kariko, a Hungary native, made…
-
Penn Medicine Gene Therapy Doctor Signs Deal with Center for Breakthrough Medicines in King of Prussia
University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process to King of Prussia’s Center for Breakthrough Medicines, writes Erin Arvedlund for The Philadelphia Inquirer. In turn, the center has the exclusive right to make the gene therapy lab’s process available…
-
Main Line Pharmaceutical Company Partners With Jennifer Aniston on Insomnia Commercial
Actress Jennifer Aniston talks about her struggles with insomnia in a commercial for Swiss pharmaceutical company Idorsia, which has U.S. operations on the Main Line, writes John George for Philadelphia Business Journal. The television and online commercials start Monday and run a week after Idorsia received clearance from the U.S. Food and Drug Administration to…
-
King of Prussia’s Center for Breakthrough Medicines Land Major Investment from South Korean Conglomerate SK
The Center for Breakthrough Medicines, which is based within MLP Ventures’ Discovery Labs innovation hub campus in King of Prussia, has secured an equity investment of $350 million from South Korean conglomerate SK, writes John George for the Philadelphia Business Journal. Together, the two organizations plan to create the largest end-to-end cell and gene therapy…
-
mRNA Vaccine Work by Abington’s Dr. Katalin Karikó Brought to Forefront by Pandemic
Dr. Katalin Karikó, an Abington resident and senior vice president of BioNTech, has been researching the mRNA vaccine for decades, but it was only after the outbreak of the coronavirus that the public took notice, write Emma Court and Nic Querolo for Bloomberg. Her current company has teamed up with Pfizer to create the first…
-
Revolutionary mRNA Research by Abington Biochemist Katalin Karikó Could Be Key to Solving Scores of Health Problems
The revolutionary mRNA research by Abington biochemist Katalin Karikó and her collaborator immunologist Drew Weissman could be the key to solving scores of health problems, writes Tim Smedley for the BBC. Their work went mostly unrecognized by the wider public before the pandemic. However, once the first COVID-19 vaccine was developed using their mRNA technology…
-
Life Sciences PA Moving to New Headquarters in King of Prussia
Life Sciences PA (LSPA) has announced they are moving its headquarters from its current location on Swedesford Rd. in Wayne to 411 Swedeland Road in King of Prussia, PA. The expanded space and rising hub of life sciences in southeastern PA will be the Association’s new home beginning February 2022. “The decision to move was…
-
Wall Street Journal: Abington Scientist Saw Vast Potential of mRNA Technology Long Before Others
While many are singing praises to mRNA technology following the development of highly adaptable COVID-19 vaccines, Dr. Katalin Kariko, an Abington biochemist, was among the first to realize the vast potential of the technology for treating various diseases, writes Allysia Finley for The Wall Street Journal. Kariko is a Hungarian immigrant who came to Pennsylvania…
-
Johnson & Johnson’s Fort Washington-based Consumer Division Selling Tylenol to Become Separate Company
Johnson & Johnson has decided to split off its $15-billion-a-year consumer division that sells many well-known brands, including Tylenol medicines produced in Fort Washington, into a separate company, write Jonathan D. Rockoff and Peter Loftus for The Wall Street Journal. The company’s storied but slower growing group will separate from the prescription-drug and medical-device businesses…
-
‘Smallpox’ Labeled Vials Found at Merck Lab in Upper Gwynedd Township
According to the Centers for Disease Control, a batch of vials labeled with “smallpox” were found in a freezer at a Merck facility in Upper Gwynedd Township and immediately quarantined, write Deanna Durante and Brian X. McCrone for NBC4 New York. It is not clear why the vials were there. Smallpox is a deadly disease…
-
Johnson & Johnson, With Significant Presence in Montgomery County, to Separate Into Two Businesses
Johnson & Johnson, with a significant presence in Montgomery County, will separate into two public businesses, writes John George for the Philadelphia Business Journal. One company will be focused on consumer health products, while the other will focus on pharmaceuticals and medical devices, where it will become two businesses Johnson & Johnson is based in…
-
Lower Gwynedd-based Anpac Bio-Medical Expects to Raise $2.5M in Public Stock Offering
Anpac Bio-Medical Science, a Chinese biotechnology company with its U.S. headquarters in Lower Gwynedd, expects to raise $2.5 million in a public stock offering, writes John George for the Philadelphia Business Journal. The company that focuses on early cancer screening and detection is currently offering 1.13 million American depository shares at $2.22 per share. And…
-
Souderton-based Almac Group Plans to Hire 300 Employees, Primarily at Its Three Montco Locations
Almac Group, with its U.S. headquarters in Souderton, is planning to hire 300 people over the next three years to grow its U.S. operations, writes John George for the Philadelphia Business Journal. The majority of these new jobs will be in Montgomery County. Here the global contract pharmaceutical development and manufacturing organization has two…
-
Bryn Mawr’s John Furey Stays “Hands-On,” Bio-Tech Firm Triples in Size
It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as COO of Spark Therapeutics, and become an advisor to various companies. But Imvax Chief Executive Officer John Furey of Bryn Mawr soon realized his passion was to stay hands-on, writes Elaine Quilici for pharmexec.com. “I…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
